Compare Enovix Corporation (ENVX) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enovix Corporation vs uniQure N.V. Ordinary Shares — how do they compare? Enovix Corporation trades at $2.48 (market cap $534.36M), while uniQure N.V. Ordinary Shares trades at $21.98 (market cap $1.45B). The key difference: uniQure N.V. Ordinary Shares is far larger — about 2.7× Enovix Corporation's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| ENVX | QURE | |
|---|---|---|
Market Cap | $534.36M | $1.45B |
Volume | 19,399,057 | 3,323,243 |
Sector | Industrials | Health |
52-Week High | $13.19 | $70.59 |
52-Week Low | $2.44 | $9.03 |
Typical Hold Time | 11 Days | 0 Days |
Enterprise Value | $596.06M | $707.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.445, down 2.59% on the day, reflecting a bearish technical trend. The company continues to report significant losses, with a net income margin of -473.89% in 2026, though it has beaten EPS estimates for the last three quarters. Recent news highlights a CEO transition and strategic focus on expanding drone battery capacity, while analyst consensus remains strongly positive with a $9.60 price target.
The outlook is challenged by persistent cash burn and high execution risks, but substantial analyst buy ratings and institutional interest, including a major stake by BlackRock, suggest long-term potential if the company can achieve profitability and scale its manufacturing capabilities as planned.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
